Allogenic Hematopoietic Cell Transplant in Hematological Malignancies: Controversies and Perspective
The Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), since the experiments in rodents in the 50’s, has become a ...
A novel regimen significantly reduced risk for moderate to severe chronic graft-versus-host disease for certain patients who ...
The following is a summary of “Improved survival in older patients with myeloid malignancies undergoing haploidentical ...
Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...
Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...
The pluripotent and multipotent stem cells are found in the bone marrow, which can differentiate into any tissue in the body.
U.S. Completed OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematological Malignancies Hematological ...
A small study of 9 patients with POEMS syndrome evaluated the extent and time course of neurologic improvement after autologous peripheral blood stem cell transplantation. Within 3 months ...
Source Reference: Jurkunas UV, et al "Cultivated autologous limbal epithelial cell (CALEC) transplantation for limbal stem cell deficiency: A phase I/II clinical trial of the first xenobiotic-free ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback